nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—Binding and entry of HIV virion—PPIA—stomach cancer	0.066	0.161	CbGpPWpGaD
Plerixafor—CXCR4—blood vessel—stomach cancer	0.049	0.208	CbGeAlD
Plerixafor—CXCR4—hematopoietic system—stomach cancer	0.0261	0.111	CbGeAlD
Plerixafor—CXCR4—Early Phase of HIV Life Cycle—PPIA—stomach cancer	0.0242	0.0592	CbGpPWpGaD
Plerixafor—CXCR4—epithelium—stomach cancer	0.0238	0.101	CbGeAlD
Plerixafor—CXCR4—smooth muscle tissue—stomach cancer	0.023	0.0977	CbGeAlD
Plerixafor—CXCR4—pancreas—stomach cancer	0.0212	0.0903	CbGeAlD
Plerixafor—CXCR4—lymphoid tissue—stomach cancer	0.0184	0.0781	CbGeAlD
Plerixafor—CXCR4—digestive system—stomach cancer	0.0181	0.0771	CbGeAlD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—ITGA5—stomach cancer	0.0175	0.0428	CbGpPWpGaD
Plerixafor—CXCR4—bone marrow—stomach cancer	0.0167	0.0711	CbGeAlD
Plerixafor—CXCR4—endocrine gland—stomach cancer	0.015	0.0637	CbGeAlD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—ACTC1—stomach cancer	0.0149	0.0364	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—BNIP3—stomach cancer	0.014	0.0343	CbGpPWpGaD
Plerixafor—CXCR4—liver—stomach cancer	0.0135	0.0575	CbGeAlD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—PLIN2—stomach cancer	0.0117	0.0287	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—NT5E—stomach cancer	0.0111	0.0272	CbGpPWpGaD
Plerixafor—CXCR4—lymph node—stomach cancer	0.0104	0.044	CbGeAlD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—RORA—stomach cancer	0.00824	0.0202	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—NPM1—stomach cancer	0.00743	0.0182	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—PAX6—stomach cancer	0.00708	0.0173	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—KISS1R—stomach cancer	0.00631	0.0154	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—ENO1—stomach cancer	0.00585	0.0143	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—AGTR2—stomach cancer	0.00563	0.0138	CbGpPWpGaD
Plerixafor—CXCR4—S1P3 pathway—RHOA—stomach cancer	0.00538	0.0132	CbGpPWpGaD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—RHOA—stomach cancer	0.00442	0.0108	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—HMOX1—stomach cancer	0.00427	0.0104	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—KISS1R—stomach cancer	0.00423	0.0103	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—SMAD4—stomach cancer	0.0041	0.01	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—KISS1—stomach cancer	0.00406	0.00994	CbGpPWpGaD
Plerixafor—CXCR4—HIV Life Cycle—PPIA—stomach cancer	0.00393	0.00961	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—HRH4—stomach cancer	0.00385	0.00941	CbGpPWpGaD
Plerixafor—CXCR4—S1P3 pathway—VEGFA—stomach cancer	0.00384	0.00939	CbGpPWpGaD
Plerixafor—CXCR4—S1P3 pathway—MAPK3—stomach cancer	0.00363	0.00888	CbGpPWpGaD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—MMP9—stomach cancer	0.00351	0.00858	CbGpPWpGaD
Plerixafor—CXCR4—S1P3 pathway—MAPK1—stomach cancer	0.00346	0.00845	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—KISS1R—stomach cancer	0.00322	0.00788	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—FYN—stomach cancer	0.00321	0.00784	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL1B—stomach cancer	0.00311	0.00762	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—HRH4—stomach cancer	0.00306	0.00748	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—NPM1—stomach cancer	0.00288	0.00704	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—KISS1—stomach cancer	0.00273	0.00667	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—PPIA—stomach cancer	0.00271	0.00664	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—AGTR2—stomach cancer	0.00265	0.00648	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—F2R—stomach cancer	0.00262	0.00641	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—SERPINE1—stomach cancer	0.00257	0.00628	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CXCL8—stomach cancer	0.00248	0.00607	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—ANXA1—stomach cancer	0.00246	0.00602	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—HRH4—stomach cancer	0.00233	0.0057	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—AGTR2—stomach cancer	0.00223	0.00547	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—HTR1A—stomach cancer	0.00215	0.00526	CbGpPWpGaD
Plerixafor—CXCR4—HIV Life Cycle—ERCC2—stomach cancer	0.0021	0.00513	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—ANXA1—stomach cancer	0.00208	0.00508	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—KISS1—stomach cancer	0.00208	0.00508	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	0.00207	0.00507	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	0.00205	0.00502	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—RHOA—stomach cancer	0.00204	0.005	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—JUN—stomach cancer	0.00202	0.00494	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	0.002	0.00488	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—ADRB1—stomach cancer	0.00187	0.00457	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—stomach cancer	0.00182	0.00446	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—KISS1R—stomach cancer	0.00182	0.00445	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	0.00178	0.00435	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—VEGFA—stomach cancer	0.00177	0.00432	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	0.00176	0.0043	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.00171	0.00418	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—KISS1R—stomach cancer	0.00165	0.00404	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.00165	0.00404	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—MMP9—stomach cancer	0.00162	0.00397	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.0016	0.00391	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.00151	0.0037	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—FYN—stomach cancer	0.00151	0.00369	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—ERCC2—stomach cancer	0.00145	0.00354	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—STAT3—stomach cancer	0.00144	0.00353	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PGLS—stomach cancer	0.00139	0.00341	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—AGTR2—stomach cancer	0.00135	0.00331	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—F2R—stomach cancer	0.00134	0.00327	CbGpPWpGaD
Plerixafor—CXCR4—Disease—RBP1—stomach cancer	0.00133	0.00325	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—HRH4—stomach cancer	0.00132	0.00322	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—HTR1A—stomach cancer	0.0013	0.00319	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.0013	0.00317	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—ANXA1—stomach cancer	0.00126	0.00308	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—ADRB1—stomach cancer	0.00122	0.00298	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HRH4—stomach cancer	0.0012	0.00292	CbGpPWpGaD
Plerixafor—CXCR4—Disease—FBP1—stomach cancer	0.00119	0.0029	CbGpPWpGaD
Plerixafor—Discomfort—Fluorouracil—stomach cancer	0.00118	0.00331	CcSEcCtD
Plerixafor—Shock—Irinotecan—stomach cancer	0.00117	0.0033	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—KISS1—stomach cancer	0.00117	0.00287	CbGpPWpGaD
Plerixafor—Nervous system disorder—Irinotecan—stomach cancer	0.00117	0.00329	CcSEcCtD
Plerixafor—Haemoglobin—Docetaxel—stomach cancer	0.00117	0.00328	CcSEcCtD
Plerixafor—Haemorrhage—Docetaxel—stomach cancer	0.00116	0.00326	CcSEcCtD
Plerixafor—Hyperhidrosis—Irinotecan—stomach cancer	0.00115	0.00324	CcSEcCtD
Plerixafor—Anaphylactic shock—Fluorouracil—stomach cancer	0.00114	0.00321	CcSEcCtD
Plerixafor—Connective tissue disorder—Docetaxel—stomach cancer	0.00114	0.0032	CcSEcCtD
Plerixafor—CXCR4—CXCR4-mediated signaling events—PIK3CA—stomach cancer	0.00114	0.00278	CbGpPWpGaD
Plerixafor—Haemoglobin—Capecitabine—stomach cancer	0.00113	0.00317	CcSEcCtD
Plerixafor—Haemorrhage—Capecitabine—stomach cancer	0.00112	0.00316	CcSEcCtD
Plerixafor—Nervous system disorder—Fluorouracil—stomach cancer	0.00112	0.00315	CcSEcCtD
Plerixafor—Connective tissue disorder—Capecitabine—stomach cancer	0.00111	0.0031	CcSEcCtD
Plerixafor—Insomnia—Irinotecan—stomach cancer	0.00108	0.00303	CcSEcCtD
Plerixafor—Paraesthesia—Irinotecan—stomach cancer	0.00107	0.00301	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—KISS1—stomach cancer	0.00107	0.00261	CbGpPWpGaD
Plerixafor—Dyspnoea—Irinotecan—stomach cancer	0.00106	0.00299	CcSEcCtD
Plerixafor—CXCR4—Disease—PGAM1—stomach cancer	0.00106	0.00259	CbGpPWpGaD
Plerixafor—Dyspepsia—Irinotecan—stomach cancer	0.00105	0.00295	CcSEcCtD
Plerixafor—Immune system disorder—Docetaxel—stomach cancer	0.00105	0.00295	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.00104	0.00292	CcSEcCtD
Plerixafor—Orthostatic hypotension—Epirubicin—stomach cancer	0.00103	0.0029	CcSEcCtD
Plerixafor—Insomnia—Fluorouracil—stomach cancer	0.00103	0.0029	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00103	0.00289	CcSEcCtD
Plerixafor—Fatigue—Irinotecan—stomach cancer	0.00103	0.00289	CcSEcCtD
Plerixafor—Paraesthesia—Fluorouracil—stomach cancer	0.00103	0.00288	CcSEcCtD
Plerixafor—Pain—Irinotecan—stomach cancer	0.00102	0.00287	CcSEcCtD
Plerixafor—Constipation—Irinotecan—stomach cancer	0.00102	0.00287	CcSEcCtD
Plerixafor—Dyspnoea—Fluorouracil—stomach cancer	0.00102	0.00286	CcSEcCtD
Plerixafor—Mental disorder—Docetaxel—stomach cancer	0.00102	0.00286	CcSEcCtD
Plerixafor—Immune system disorder—Capecitabine—stomach cancer	0.00102	0.00285	CcSEcCtD
Plerixafor—Erythema—Docetaxel—stomach cancer	0.00101	0.00284	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—RGS2—stomach cancer	0.00101	0.00247	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GAST—stomach cancer	0.00101	0.00247	CbGpPWpGaD
Plerixafor—CXCR4—Disease—WIF1—stomach cancer	0.00101	0.00247	CbGpPWpGaD
Plerixafor—Dyspepsia—Fluorouracil—stomach cancer	0.00101	0.00283	CcSEcCtD
Plerixafor—Abdominal discomfort—Methotrexate—stomach cancer	0.001	0.00282	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000987	0.00277	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—ADRB2—stomach cancer	0.000987	0.00241	CbGpPWpGaD
Plerixafor—Abdominal distension—Epirubicin—stomach cancer	0.000985	0.00277	CcSEcCtD
Plerixafor—Mental disorder—Capecitabine—stomach cancer	0.000985	0.00277	CcSEcCtD
Plerixafor—Feeling abnormal—Irinotecan—stomach cancer	0.000984	0.00276	CcSEcCtD
Plerixafor—Erythema—Capecitabine—stomach cancer	0.000979	0.00275	CcSEcCtD
Plerixafor—Pain—Fluorouracil—stomach cancer	0.000978	0.00275	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—KISS1R—stomach cancer	0.000976	0.00239	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GLI3—stomach cancer	0.000976	0.00239	CbGpPWpGaD
Plerixafor—Gastrointestinal pain—Irinotecan—stomach cancer	0.000976	0.00274	CcSEcCtD
Plerixafor—Flatulence—Capecitabine—stomach cancer	0.000965	0.00271	CcSEcCtD
Plerixafor—Orthostatic hypotension—Doxorubicin—stomach cancer	0.000957	0.00269	CcSEcCtD
Plerixafor—CXCR4—Disease—RPL18—stomach cancer	0.000948	0.00232	CbGpPWpGaD
Plerixafor—CXCR4—Disease—RPL13—stomach cancer	0.000948	0.00232	CbGpPWpGaD
Plerixafor—Abdominal pain—Irinotecan—stomach cancer	0.000944	0.00265	CcSEcCtD
Plerixafor—Feeling abnormal—Fluorouracil—stomach cancer	0.000942	0.00265	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CXCL8—stomach cancer	0.000933	0.00228	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RBP1—stomach cancer	0.000931	0.00228	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GAST—stomach cancer	0.000916	0.00224	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—RGS2—stomach cancer	0.000916	0.00224	CbGpPWpGaD
Plerixafor—Abdominal distension—Doxorubicin—stomach cancer	0.000912	0.00256	CcSEcCtD
Plerixafor—Ill-defined disorder—Capecitabine—stomach cancer	0.000908	0.00255	CcSEcCtD
Plerixafor—Urticaria—Fluorouracil—stomach cancer	0.000908	0.00255	CcSEcCtD
Plerixafor—Syncope—Docetaxel—stomach cancer	0.000907	0.00255	CcSEcCtD
Plerixafor—CXCR4—Disease—RNF43—stomach cancer	0.000899	0.0022	CbGpPWpGaD
Plerixafor—Loss of consciousness—Docetaxel—stomach cancer	0.000889	0.0025	CcSEcCtD
Plerixafor—CXCR4—Disease—RPS15—stomach cancer	0.000884	0.00216	CbGpPWpGaD
Plerixafor—CXCR4—Disease—RPS21—stomach cancer	0.000884	0.00216	CbGpPWpGaD
Plerixafor—Malaise—Capecitabine—stomach cancer	0.000883	0.00248	CcSEcCtD
Plerixafor—Hypersensitivity—Irinotecan—stomach cancer	0.000879	0.00247	CcSEcCtD
Plerixafor—Syncope—Capecitabine—stomach cancer	0.000878	0.00246	CcSEcCtD
Plerixafor—Arthralgia—Docetaxel—stomach cancer	0.000861	0.00242	CcSEcCtD
Plerixafor—Loss of consciousness—Capecitabine—stomach cancer	0.00086	0.00242	CcSEcCtD
Plerixafor—Asthenia—Irinotecan—stomach cancer	0.000856	0.0024	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000855	0.0024	CcSEcCtD
Plerixafor—Hypersensitivity—Fluorouracil—stomach cancer	0.000842	0.00237	CcSEcCtD
Plerixafor—Dry mouth—Docetaxel—stomach cancer	0.000842	0.00236	CcSEcCtD
Plerixafor—Haemoglobin—Methotrexate—stomach cancer	0.000841	0.00236	CcSEcCtD
Plerixafor—Haemorrhage—Methotrexate—stomach cancer	0.000837	0.00235	CcSEcCtD
Plerixafor—Arthralgia—Capecitabine—stomach cancer	0.000833	0.00234	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000828	0.00232	CcSEcCtD
Plerixafor—Anaphylactic shock—Docetaxel—stomach cancer	0.000825	0.00232	CcSEcCtD
Plerixafor—Discomfort—Capecitabine—stomach cancer	0.000823	0.00231	CcSEcCtD
Plerixafor—Diarrhoea—Irinotecan—stomach cancer	0.000817	0.00229	CcSEcCtD
Plerixafor—Dry mouth—Capecitabine—stomach cancer	0.000815	0.00229	CcSEcCtD
Plerixafor—Shock—Docetaxel—stomach cancer	0.000812	0.00228	CcSEcCtD
Plerixafor—Nervous system disorder—Docetaxel—stomach cancer	0.000809	0.00227	CcSEcCtD
Plerixafor—Pruritus—Fluorouracil—stomach cancer	0.000809	0.00227	CcSEcCtD
Plerixafor—Skin disorder—Docetaxel—stomach cancer	0.000801	0.00225	CcSEcCtD
Plerixafor—Dizziness—Irinotecan—stomach cancer	0.000789	0.00222	CcSEcCtD
Plerixafor—Haemoglobin—Epirubicin—stomach cancer	0.000787	0.00221	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—CXCL8—stomach cancer	0.000787	0.00193	CbGpPWpGaD
Plerixafor—Shock—Capecitabine—stomach cancer	0.000786	0.00221	CcSEcCtD
Plerixafor—Nervous system disorder—Capecitabine—stomach cancer	0.000783	0.0022	CcSEcCtD
Plerixafor—Haemorrhage—Epirubicin—stomach cancer	0.000783	0.0022	CcSEcCtD
Plerixafor—Diarrhoea—Fluorouracil—stomach cancer	0.000782	0.0022	CcSEcCtD
Plerixafor—Skin disorder—Capecitabine—stomach cancer	0.000776	0.00218	CcSEcCtD
Plerixafor—Hyperhidrosis—Capecitabine—stomach cancer	0.000772	0.00217	CcSEcCtD
Plerixafor—Connective tissue disorder—Epirubicin—stomach cancer	0.00077	0.00216	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—AGTR2—stomach cancer	0.000764	0.00187	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—WWOX—stomach cancer	0.000759	0.00186	CbGpPWpGaD
Plerixafor—Vomiting—Irinotecan—stomach cancer	0.000759	0.00213	CcSEcCtD
Plerixafor—Immune system disorder—Methotrexate—stomach cancer	0.000756	0.00212	CcSEcCtD
Plerixafor—Dizziness—Fluorouracil—stomach cancer	0.000756	0.00212	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—F2R—stomach cancer	0.000756	0.00185	CbGpPWpGaD
Plerixafor—Rash—Irinotecan—stomach cancer	0.000753	0.00211	CcSEcCtD
Plerixafor—Dermatitis—Irinotecan—stomach cancer	0.000752	0.00211	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000752	0.00211	CcSEcCtD
Plerixafor—Headache—Irinotecan—stomach cancer	0.000748	0.0021	CcSEcCtD
Plerixafor—Insomnia—Docetaxel—stomach cancer	0.000746	0.0021	CcSEcCtD
Plerixafor—Paraesthesia—Docetaxel—stomach cancer	0.000741	0.00208	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—HTR1A—stomach cancer	0.000736	0.0018	CbGpPWpGaD
Plerixafor—Dyspnoea—Docetaxel—stomach cancer	0.000736	0.00207	CcSEcCtD
Plerixafor—Mental disorder—Methotrexate—stomach cancer	0.000733	0.00206	CcSEcCtD
Plerixafor—CXCR4—Disease—ALDOB—stomach cancer	0.000732	0.00179	CbGpPWpGaD
Plerixafor—Erythema—Methotrexate—stomach cancer	0.000729	0.00205	CcSEcCtD
Plerixafor—Haemoglobin—Doxorubicin—stomach cancer	0.000729	0.00205	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000728	0.00204	CcSEcCtD
Plerixafor—Vomiting—Fluorouracil—stomach cancer	0.000727	0.00204	CcSEcCtD
Plerixafor—Dyspepsia—Docetaxel—stomach cancer	0.000726	0.00204	CcSEcCtD
Plerixafor—Haemorrhage—Doxorubicin—stomach cancer	0.000725	0.00204	CcSEcCtD
Plerixafor—Insomnia—Capecitabine—stomach cancer	0.000723	0.00203	CcSEcCtD
Plerixafor—Rash—Fluorouracil—stomach cancer	0.000721	0.00202	CcSEcCtD
Plerixafor—Dermatitis—Fluorouracil—stomach cancer	0.00072	0.00202	CcSEcCtD
Plerixafor—CXCR4—Disease—RPL15—stomach cancer	0.000718	0.00176	CbGpPWpGaD
Plerixafor—Paraesthesia—Capecitabine—stomach cancer	0.000717	0.00201	CcSEcCtD
Plerixafor—Headache—Fluorouracil—stomach cancer	0.000716	0.00201	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000712	0.002	CcSEcCtD
Plerixafor—Connective tissue disorder—Doxorubicin—stomach cancer	0.000712	0.002	CcSEcCtD
Plerixafor—Dyspnoea—Capecitabine—stomach cancer	0.000712	0.002	CcSEcCtD
Plerixafor—Fatigue—Docetaxel—stomach cancer	0.000711	0.002	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—ANXA1—stomach cancer	0.000711	0.00174	CbGpPWpGaD
Plerixafor—Nausea—Irinotecan—stomach cancer	0.000709	0.00199	CcSEcCtD
Plerixafor—Immune system disorder—Epirubicin—stomach cancer	0.000708	0.00199	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—WIF1—stomach cancer	0.000706	0.00173	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HRH4—stomach cancer	0.000706	0.00173	CbGpPWpGaD
Plerixafor—Constipation—Docetaxel—stomach cancer	0.000706	0.00198	CcSEcCtD
Plerixafor—Pain—Docetaxel—stomach cancer	0.000706	0.00198	CcSEcCtD
Plerixafor—CXCR4—Disease—NPM1—stomach cancer	0.000705	0.00173	CbGpPWpGaD
Plerixafor—Dyspepsia—Capecitabine—stomach cancer	0.000703	0.00197	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—AGTR2—stomach cancer	0.000694	0.0017	CbGpPWpGaD
Plerixafor—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00069	0.00194	CcSEcCtD
Plerixafor—Fatigue—Capecitabine—stomach cancer	0.000689	0.00193	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—ADRB1—stomach cancer	0.000688	0.00168	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—F2R—stomach cancer	0.000686	0.00168	CbGpPWpGaD
Plerixafor—Mental disorder—Epirubicin—stomach cancer	0.000686	0.00193	CcSEcCtD
Plerixafor—Constipation—Capecitabine—stomach cancer	0.000683	0.00192	CcSEcCtD
Plerixafor—Pain—Capecitabine—stomach cancer	0.000683	0.00192	CcSEcCtD
Plerixafor—Erythema—Epirubicin—stomach cancer	0.000682	0.00191	CcSEcCtD
Plerixafor—CXCR4—Disease—RBP4—stomach cancer	0.000681	0.00167	CbGpPWpGaD
Plerixafor—Feeling abnormal—Docetaxel—stomach cancer	0.00068	0.00191	CcSEcCtD
Plerixafor—Nausea—Fluorouracil—stomach cancer	0.000679	0.00191	CcSEcCtD
Plerixafor—Ill-defined disorder—Methotrexate—stomach cancer	0.000676	0.0019	CcSEcCtD
Plerixafor—Gastrointestinal pain—Docetaxel—stomach cancer	0.000675	0.00189	CcSEcCtD
Plerixafor—Flatulence—Epirubicin—stomach cancer	0.000672	0.00189	CcSEcCtD
Plerixafor—CXCR4—Disease—RPS26—stomach cancer	0.00067	0.00164	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HTR1A—stomach cancer	0.000668	0.00163	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PPIA—stomach cancer	0.000665	0.00163	CbGpPWpGaD
Plerixafor—Feeling abnormal—Capecitabine—stomach cancer	0.000658	0.00185	CcSEcCtD
Plerixafor—Malaise—Methotrexate—stomach cancer	0.000657	0.00185	CcSEcCtD
Plerixafor—Immune system disorder—Doxorubicin—stomach cancer	0.000655	0.00184	CcSEcCtD
Plerixafor—Gastrointestinal pain—Capecitabine—stomach cancer	0.000653	0.00183	CcSEcCtD
Plerixafor—Abdominal pain—Docetaxel—stomach cancer	0.000652	0.00183	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—PRKAB1—stomach cancer	0.000651	0.00159	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—ANXA1—stomach cancer	0.000645	0.00158	CbGpPWpGaD
Plerixafor—Mental disorder—Doxorubicin—stomach cancer	0.000635	0.00178	CcSEcCtD
Plerixafor—Urticaria—Capecitabine—stomach cancer	0.000635	0.00178	CcSEcCtD
Plerixafor—Ill-defined disorder—Epirubicin—stomach cancer	0.000633	0.00178	CcSEcCtD
Plerixafor—Abdominal pain—Capecitabine—stomach cancer	0.000632	0.00177	CcSEcCtD
Plerixafor—Erythema—Doxorubicin—stomach cancer	0.000631	0.00177	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—KISS1—stomach cancer	0.000629	0.00154	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RNF43—stomach cancer	0.000629	0.00154	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000626	0.00153	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—ADRB1—stomach cancer	0.000625	0.00153	CbGpPWpGaD
Plerixafor—Flatulence—Doxorubicin—stomach cancer	0.000622	0.00175	CcSEcCtD
Plerixafor—Arthralgia—Methotrexate—stomach cancer	0.00062	0.00174	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000616	0.00173	CcSEcCtD
Plerixafor—Malaise—Epirubicin—stomach cancer	0.000615	0.00173	CcSEcCtD
Plerixafor—Discomfort—Methotrexate—stomach cancer	0.000613	0.00172	CcSEcCtD
Plerixafor—Syncope—Epirubicin—stomach cancer	0.000612	0.00172	CcSEcCtD
Plerixafor—Hypersensitivity—Docetaxel—stomach cancer	0.000608	0.00171	CcSEcCtD
Plerixafor—Loss of consciousness—Epirubicin—stomach cancer	0.000599	0.00168	CcSEcCtD
Plerixafor—Anaphylactic shock—Methotrexate—stomach cancer	0.000595	0.00167	CcSEcCtD
Plerixafor—Asthenia—Docetaxel—stomach cancer	0.000592	0.00166	CcSEcCtD
Plerixafor—Hypersensitivity—Capecitabine—stomach cancer	0.000589	0.00165	CcSEcCtD
Plerixafor—Ill-defined disorder—Doxorubicin—stomach cancer	0.000585	0.00164	CcSEcCtD
Plerixafor—Pruritus—Docetaxel—stomach cancer	0.000584	0.00164	CcSEcCtD
Plerixafor—Nervous system disorder—Methotrexate—stomach cancer	0.000583	0.00164	CcSEcCtD
Plerixafor—Arthralgia—Epirubicin—stomach cancer	0.000581	0.00163	CcSEcCtD
Plerixafor—Skin disorder—Methotrexate—stomach cancer	0.000578	0.00162	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000577	0.00162	CcSEcCtD
Plerixafor—Hyperhidrosis—Methotrexate—stomach cancer	0.000575	0.00161	CcSEcCtD
Plerixafor—Discomfort—Epirubicin—stomach cancer	0.000574	0.00161	CcSEcCtD
Plerixafor—Asthenia—Capecitabine—stomach cancer	0.000573	0.00161	CcSEcCtD
Plerixafor—CXCR4—Disease—AKR1C3—stomach cancer	0.00057	0.00139	CbGpPWpGaD
Plerixafor—CXCR4—Disease—RPS19—stomach cancer	0.00057	0.00139	CbGpPWpGaD
Plerixafor—Malaise—Doxorubicin—stomach cancer	0.000569	0.0016	CcSEcCtD
Plerixafor—Dry mouth—Epirubicin—stomach cancer	0.000568	0.00159	CcSEcCtD
Plerixafor—Syncope—Doxorubicin—stomach cancer	0.000566	0.00159	CcSEcCtD
Plerixafor—Pruritus—Capecitabine—stomach cancer	0.000565	0.00159	CcSEcCtD
Plerixafor—Diarrhoea—Docetaxel—stomach cancer	0.000565	0.00159	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—FST—stomach cancer	0.000561	0.00137	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—ADRB2—stomach cancer	0.000558	0.00136	CbGpPWpGaD
Plerixafor—Anaphylactic shock—Epirubicin—stomach cancer	0.000557	0.00156	CcSEcCtD
Plerixafor—CXCR4—Disease—ENO1—stomach cancer	0.000555	0.00136	CbGpPWpGaD
Plerixafor—Loss of consciousness—Doxorubicin—stomach cancer	0.000555	0.00156	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—HBEGF—stomach cancer	0.000549	0.00134	CbGpPWpGaD
Plerixafor—Shock—Epirubicin—stomach cancer	0.000548	0.00154	CcSEcCtD
Plerixafor—Diarrhoea—Capecitabine—stomach cancer	0.000547	0.00153	CcSEcCtD
Plerixafor—Nervous system disorder—Epirubicin—stomach cancer	0.000546	0.00153	CcSEcCtD
Plerixafor—Dizziness—Docetaxel—stomach cancer	0.000546	0.00153	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000542	0.00152	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—GAST—stomach cancer	0.000541	0.00132	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RGS2—stomach cancer	0.000541	0.00132	CbGpPWpGaD
Plerixafor—Skin disorder—Epirubicin—stomach cancer	0.000541	0.00152	CcSEcCtD
Plerixafor—Hyperhidrosis—Epirubicin—stomach cancer	0.000538	0.00151	CcSEcCtD
Plerixafor—Insomnia—Methotrexate—stomach cancer	0.000538	0.00151	CcSEcCtD
Plerixafor—Arthralgia—Doxorubicin—stomach cancer	0.000537	0.00151	CcSEcCtD
Plerixafor—Paraesthesia—Methotrexate—stomach cancer	0.000534	0.0015	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000533	0.0015	CcSEcCtD
Plerixafor—Discomfort—Doxorubicin—stomach cancer	0.000531	0.00149	CcSEcCtD
Plerixafor—Dyspnoea—Methotrexate—stomach cancer	0.00053	0.00149	CcSEcCtD
Plerixafor—Dizziness—Capecitabine—stomach cancer	0.000528	0.00148	CcSEcCtD
Plerixafor—Dry mouth—Doxorubicin—stomach cancer	0.000525	0.00148	CcSEcCtD
Plerixafor—Vomiting—Docetaxel—stomach cancer	0.000525	0.00147	CcSEcCtD
Plerixafor—Dyspepsia—Methotrexate—stomach cancer	0.000524	0.00147	CcSEcCtD
Plerixafor—Rash—Docetaxel—stomach cancer	0.00052	0.00146	CcSEcCtD
Plerixafor—Dermatitis—Docetaxel—stomach cancer	0.00052	0.00146	CcSEcCtD
Plerixafor—Headache—Docetaxel—stomach cancer	0.000517	0.00145	CcSEcCtD
Plerixafor—Anaphylactic shock—Doxorubicin—stomach cancer	0.000515	0.00145	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000513	0.00144	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—FGG—stomach cancer	0.000513	0.00125	CbGpPWpGaD
Plerixafor—Fatigue—Methotrexate—stomach cancer	0.000513	0.00144	CcSEcCtD
Plerixafor—Pain—Methotrexate—stomach cancer	0.000509	0.00143	CcSEcCtD
Plerixafor—Vomiting—Capecitabine—stomach cancer	0.000508	0.00143	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000507	0.00142	CcSEcCtD
Plerixafor—Shock—Doxorubicin—stomach cancer	0.000507	0.00142	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—ADRB2—stomach cancer	0.000506	0.00124	CbGpPWpGaD
Plerixafor—Nervous system disorder—Doxorubicin—stomach cancer	0.000505	0.00142	CcSEcCtD
Plerixafor—Rash—Capecitabine—stomach cancer	0.000504	0.00141	CcSEcCtD
Plerixafor—CXCR4—Disease—RPS6—stomach cancer	0.000504	0.00123	CbGpPWpGaD
Plerixafor—Insomnia—Epirubicin—stomach cancer	0.000503	0.00141	CcSEcCtD
Plerixafor—Dermatitis—Capecitabine—stomach cancer	0.000503	0.00141	CcSEcCtD
Plerixafor—Headache—Capecitabine—stomach cancer	0.0005	0.00141	CcSEcCtD
Plerixafor—Skin disorder—Doxorubicin—stomach cancer	0.0005	0.0014	CcSEcCtD
Plerixafor—Paraesthesia—Epirubicin—stomach cancer	0.0005	0.0014	CcSEcCtD
Plerixafor—Hyperhidrosis—Doxorubicin—stomach cancer	0.000498	0.0014	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—PPP2R1A—stomach cancer	0.000496	0.00121	CbGpPWpGaD
Plerixafor—Dyspnoea—Epirubicin—stomach cancer	0.000496	0.00139	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—PRKAA1—stomach cancer	0.000494	0.00121	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CD44—stomach cancer	0.000492	0.0012	CbGpPWpGaD
Plerixafor—Nausea—Docetaxel—stomach cancer	0.00049	0.00138	CcSEcCtD
Plerixafor—Feeling abnormal—Methotrexate—stomach cancer	0.00049	0.00138	CcSEcCtD
Plerixafor—Dyspepsia—Epirubicin—stomach cancer	0.00049	0.00138	CcSEcCtD
Plerixafor—Gastrointestinal pain—Methotrexate—stomach cancer	0.000486	0.00137	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Epirubicin—stomach cancer	0.00048	0.00135	CcSEcCtD
Plerixafor—Fatigue—Epirubicin—stomach cancer	0.00048	0.00135	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—RBP4—stomach cancer	0.000477	0.00117	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CXCL8—stomach cancer	0.000477	0.00117	CbGpPWpGaD
Plerixafor—Pain—Epirubicin—stomach cancer	0.000476	0.00134	CcSEcCtD
Plerixafor—Constipation—Epirubicin—stomach cancer	0.000476	0.00134	CcSEcCtD
Plerixafor—Nausea—Capecitabine—stomach cancer	0.000475	0.00133	CcSEcCtD
Plerixafor—Urticaria—Methotrexate—stomach cancer	0.000472	0.00133	CcSEcCtD
Plerixafor—Abdominal pain—Methotrexate—stomach cancer	0.00047	0.00132	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000469	0.00132	CcSEcCtD
Plerixafor—Insomnia—Doxorubicin—stomach cancer	0.000466	0.00131	CcSEcCtD
Plerixafor—CXCR4—Disease—HBEGF—stomach cancer	0.000463	0.00113	CbGpPWpGaD
Plerixafor—Paraesthesia—Doxorubicin—stomach cancer	0.000462	0.0013	CcSEcCtD
Plerixafor—Dyspnoea—Doxorubicin—stomach cancer	0.000459	0.00129	CcSEcCtD
Plerixafor—Feeling abnormal—Epirubicin—stomach cancer	0.000459	0.00129	CcSEcCtD
Plerixafor—Gastrointestinal pain—Epirubicin—stomach cancer	0.000455	0.00128	CcSEcCtD
Plerixafor—Dyspepsia—Doxorubicin—stomach cancer	0.000453	0.00127	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000445	0.00125	CcSEcCtD
Plerixafor—Fatigue—Doxorubicin—stomach cancer	0.000444	0.00125	CcSEcCtD
Plerixafor—Urticaria—Epirubicin—stomach cancer	0.000442	0.00124	CcSEcCtD
Plerixafor—Pain—Doxorubicin—stomach cancer	0.00044	0.00124	CcSEcCtD
Plerixafor—Constipation—Doxorubicin—stomach cancer	0.00044	0.00124	CcSEcCtD
Plerixafor—Abdominal pain—Epirubicin—stomach cancer	0.00044	0.00124	CcSEcCtD
Plerixafor—Hypersensitivity—Methotrexate—stomach cancer	0.000438	0.00123	CcSEcCtD
Plerixafor—Asthenia—Methotrexate—stomach cancer	0.000427	0.0012	CcSEcCtD
Plerixafor—Feeling abnormal—Doxorubicin—stomach cancer	0.000424	0.00119	CcSEcCtD
Plerixafor—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000421	0.00118	CcSEcCtD
Plerixafor—Pruritus—Methotrexate—stomach cancer	0.000421	0.00118	CcSEcCtD
Plerixafor—CXCR4—Disease—PPP2R1A—stomach cancer	0.000419	0.00102	CbGpPWpGaD
Plerixafor—Hypersensitivity—Epirubicin—stomach cancer	0.00041	0.00115	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—HSPB1—stomach cancer	0.00041	0.001	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AGTR2—stomach cancer	0.00041	0.001	CbGpPWpGaD
Plerixafor—Urticaria—Doxorubicin—stomach cancer	0.000409	0.00115	CcSEcCtD
Plerixafor—Abdominal pain—Doxorubicin—stomach cancer	0.000407	0.00114	CcSEcCtD
Plerixafor—Diarrhoea—Methotrexate—stomach cancer	0.000407	0.00114	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—F2R—stomach cancer	0.000405	0.000992	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—BMP2—stomach cancer	0.000405	0.000992	CbGpPWpGaD
Plerixafor—Asthenia—Epirubicin—stomach cancer	0.000399	0.00112	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—AKR1C3—stomach cancer	0.000399	0.000976	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HTR1A—stomach cancer	0.000395	0.000966	CbGpPWpGaD
Plerixafor—Pruritus—Epirubicin—stomach cancer	0.000394	0.00111	CcSEcCtD
Plerixafor—Dizziness—Methotrexate—stomach cancer	0.000393	0.0011	CcSEcCtD
Plerixafor—CXCR4—Disease—SMAD4—stomach cancer	0.000389	0.000951	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PRKCB—stomach cancer	0.000382	0.000935	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ANXA1—stomach cancer	0.000381	0.000933	CbGpPWpGaD
Plerixafor—Diarrhoea—Epirubicin—stomach cancer	0.000381	0.00107	CcSEcCtD
Plerixafor—Hypersensitivity—Doxorubicin—stomach cancer	0.000379	0.00107	CcSEcCtD
Plerixafor—Vomiting—Methotrexate—stomach cancer	0.000378	0.00106	CcSEcCtD
Plerixafor—Rash—Methotrexate—stomach cancer	0.000375	0.00105	CcSEcCtD
Plerixafor—Dermatitis—Methotrexate—stomach cancer	0.000375	0.00105	CcSEcCtD
Plerixafor—Headache—Methotrexate—stomach cancer	0.000373	0.00105	CcSEcCtD
Plerixafor—Asthenia—Doxorubicin—stomach cancer	0.000369	0.00104	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—ADRB1—stomach cancer	0.000369	0.000903	CbGpPWpGaD
Plerixafor—CXCR4—Disease—FYN—stomach cancer	0.000369	0.000903	CbGpPWpGaD
Plerixafor—Dizziness—Epirubicin—stomach cancer	0.000368	0.00103	CcSEcCtD
Plerixafor—Pruritus—Doxorubicin—stomach cancer	0.000364	0.00102	CcSEcCtD
Plerixafor—CXCR4—Disease—ERCC2—stomach cancer	0.000355	0.000868	CbGpPWpGaD
Plerixafor—Vomiting—Epirubicin—stomach cancer	0.000354	0.000994	CcSEcCtD
Plerixafor—Nausea—Methotrexate—stomach cancer	0.000353	0.000992	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—RPS6—stomach cancer	0.000353	0.000863	CbGpPWpGaD
Plerixafor—Diarrhoea—Doxorubicin—stomach cancer	0.000352	0.000989	CcSEcCtD
Plerixafor—Rash—Epirubicin—stomach cancer	0.000351	0.000985	CcSEcCtD
Plerixafor—Dermatitis—Epirubicin—stomach cancer	0.000351	0.000984	CcSEcCtD
Plerixafor—Headache—Epirubicin—stomach cancer	0.000349	0.000979	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—PRKCB—stomach cancer	0.000347	0.000849	CbGpPWpGaD
Plerixafor—CXCR4—Disease—FGFR2—stomach cancer	0.000346	0.000848	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6ST—stomach cancer	0.000346	0.000846	CbGpPWpGaD
Plerixafor—Dizziness—Doxorubicin—stomach cancer	0.000341	0.000956	CcSEcCtD
Plerixafor—CXCR4—Disease—MTHFR—stomach cancer	0.000333	0.000816	CbGpPWpGaD
Plerixafor—Nausea—Epirubicin—stomach cancer	0.000331	0.000928	CcSEcCtD
Plerixafor—Vomiting—Doxorubicin—stomach cancer	0.000327	0.000919	CcSEcCtD
Plerixafor—Rash—Doxorubicin—stomach cancer	0.000325	0.000912	CcSEcCtD
Plerixafor—Dermatitis—Doxorubicin—stomach cancer	0.000324	0.000911	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—HBEGF—stomach cancer	0.000324	0.000793	CbGpPWpGaD
Plerixafor—Headache—Doxorubicin—stomach cancer	0.000323	0.000906	CcSEcCtD
Plerixafor—CXCR4—Disease—IRS2—stomach cancer	0.000317	0.000776	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6R—stomach cancer	0.000308	0.000755	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CAV1—stomach cancer	0.000308	0.000753	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APOA1—stomach cancer	0.000307	0.000751	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—RHOA—stomach cancer	0.000307	0.000751	CbGpPWpGaD
Plerixafor—Nausea—Doxorubicin—stomach cancer	0.000306	0.000859	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—ADRB2—stomach cancer	0.000299	0.000732	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PPP2R1A—stomach cancer	0.000293	0.000717	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6ST—stomach cancer	0.000292	0.000713	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APC—stomach cancer	0.00028	0.000686	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—RHOA—stomach cancer	0.000279	0.000682	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SMAD4—stomach cancer	0.000272	0.000666	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL8—stomach cancer	0.000269	0.000659	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6R—stomach cancer	0.00026	0.000637	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FYN—stomach cancer	0.000258	0.000632	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CXCL8—stomach cancer	0.000245	0.000598	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SERPINE1—stomach cancer	0.000244	0.000596	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FGFR2—stomach cancer	0.000243	0.000594	CbGpPWpGaD
Plerixafor—CXCR4—Disease—RHOA—stomach cancer	0.000235	0.000575	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOS3—stomach cancer	0.000233	0.000569	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IRS2—stomach cancer	0.000222	0.000544	CbGpPWpGaD
Plerixafor—CXCR4—Disease—ERBB2—stomach cancer	0.000218	0.000532	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CAV1—stomach cancer	0.000215	0.000527	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOA1—stomach cancer	0.000215	0.000526	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PTGS2—stomach cancer	0.000213	0.00052	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRKCB—stomach cancer	0.000205	0.000502	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6ST—stomach cancer	0.000204	0.0005	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CDKN1B—stomach cancer	0.000201	0.000493	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APC—stomach cancer	0.000196	0.00048	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—MAPK3—stomach cancer	0.000188	0.00046	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CDKN1A—stomach cancer	0.000186	0.000455	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6R—stomach cancer	0.000182	0.000446	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—MAPK1—stomach cancer	0.000179	0.000437	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—EGFR—stomach cancer	0.000179	0.000437	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PIK3CA—stomach cancer	0.000171	0.000418	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SERPINE1—stomach cancer	0.000171	0.000417	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—KRAS—stomach cancer	0.000169	0.000413	CbGpPWpGaD
Plerixafor—CXCR4—Disease—STAT3—stomach cancer	0.000166	0.000406	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RHOA—stomach cancer	0.000165	0.000403	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NOS3—stomach cancer	0.000163	0.000398	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MAPK3—stomach cancer	0.000159	0.000388	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PIK3CA—stomach cancer	0.000155	0.00038	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MYC—stomach cancer	0.000154	0.000377	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ERBB2—stomach cancer	0.000152	0.000373	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MAPK1—stomach cancer	0.000151	0.000369	CbGpPWpGaD
Plerixafor—CXCR4—Disease—EGFR—stomach cancer	0.000151	0.000369	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCL8—stomach cancer	0.000144	0.000353	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HRAS—stomach cancer	0.000144	0.000351	CbGpPWpGaD
Plerixafor—CXCR4—Disease—KRAS—stomach cancer	0.000142	0.000349	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CDKN1B—stomach cancer	0.000141	0.000345	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6—stomach cancer	0.000137	0.000336	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCND1—stomach cancer	0.000135	0.000329	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—JUN—stomach cancer	0.000134	0.000329	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PIK3CA—stomach cancer	0.000131	0.00032	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MMP9—stomach cancer	0.000131	0.00032	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CDKN1A—stomach cancer	0.00013	0.000319	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MAPK8—stomach cancer	0.000127	0.000311	CbGpPWpGaD
Plerixafor—CXCR4—Disease—HRAS—stomach cancer	0.000121	0.000296	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—VEGFA—stomach cancer	0.000117	0.000287	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—STAT3—stomach cancer	0.000116	0.000284	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6—stomach cancer	0.000116	0.000284	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MAPK3—stomach cancer	0.000111	0.000272	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MYC—stomach cancer	0.000108	0.000264	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MAPK1—stomach cancer	0.000106	0.000258	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—EGFR—stomach cancer	0.000106	0.000258	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—KRAS—stomach cancer	9.98e-05	0.000244	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PIK3CA—stomach cancer	9.16e-05	0.000224	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TP53—stomach cancer	8.87e-05	0.000217	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HRAS—stomach cancer	8.48e-05	0.000207	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6—stomach cancer	8.12e-05	0.000199	CbGpPWpGaD
